Drug Shortage Report for CISATRACURIUM BESYLATE INJECTION

Last updated on 2019-03-28 History
Report ID 1428
Drug Identification Number 02425718
Brand name CISATRACURIUM BESYLATE INJECTION
Common or Proper name Cisatracurium Besylate
Company Name PFIZER CANADA ULC
Active Ingredient(s) CISATRACURIUM
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 20 mg/10 mL x 10
ATC code M03AC
ATC description MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2015-07-30
Estimated end date Unknown
Actual end date 2019-03-25
Shortage status Resolved
Updated date 2019-03-28
Company comments Product is discontinued
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2019-03-28 French Compare
v5 2019-03-28 English Compare
v4 2017-03-14 French Compare
v3 2017-03-14 English Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare